Davita - Ebensburg is a medicare approved dialysis facility center in Ebensburg, Pennsylvania and it has 9 dialysis stations. It is located in Cambria county at 429 Manor Dr., Suite 650, Ebensburg, PA, 15931. You can reach out to the office of Davita - Ebensburg at (814) 472-2642. This dialysis clinic is managed and/or owned by Davita. Davita - Ebensburg has the following ownership type - Profit. It was first certified by medicare in May, 2001. The medicare id for this facility is 392686 and it accepts patients under medicare ESRD program.
| Name | Davita - Ebensburg |
|---|---|
| Location | 429 Manor Dr., Suite 650, Ebensburg, Pennsylvania |
| No. of Dialysis Stations | 9 |
| Medicare ID | 392686 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 429 Manor Dr., Suite 650, Ebensburg, Pennsylvania, 15931 | |
| (814) 472-2642 | |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
| NPI Number | 1417919200 |
| Organization Name | Pdi Ebensburg |
| Doing Business As | Physicians Dialysis Acquisitions Inc |
| Address | 429 Manor Dr Ebensburg, Pennsylvania, 15931 |
| Phone Number | (814) 472-2642 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 22 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 14 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 49 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 380 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
| Adult patients getting regular peritoneal dialysis at the center | 9 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 68 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Ebensburg with elevated calcium levels.
| Patients with hypercalcemia | 57 |
| Hypercalcemia patient months | 464 |
| Patients with Serumphosphor | 62 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 33 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 40 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 13 |
| Patients with Serumphosphor greater than 7 mg/dL | 3 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 31 |
| Patient months included in arterial venous fistula and catheter summaries | 200 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 52 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 24 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 41 |
| Hospitalization Rate in facility | 218.9 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 391 |
| Hospitalization Rate: Lower Confidence Limit | 128.3 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Ebensburg were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 19.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 31.2 |
| Readmission Rate: Lower Confidence Limit | 10.7 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Ebensburg get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .66 (As Expected) |
| SIR: Upper Confidence Limit | 2.2 |
| SIR: Lower Confidence Limit | .11 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Ebensburg's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 34 |
| Transfusion Rate in facility | 80.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 190 |
| Transfusion Rate: Lower Confidence Limit | 38 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Ebensburg lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 200 |
| Mortality Rate in facility | 25.3 (Worse than Expected) |
| Mortality Rate: Upper Confidence Limit | 34.1 |
| Mortality Rate: Lower Confidence Limit | 18.3 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago
Davita - Ebensburg Location: 429 Manor Dr., Suite 650, Ebensburg, Pennsylvania, 15931 Phone: (814) 472-2642 |
Prodigy Dialysis, Llc - Ebensburg Location: 1100 West High Street, Ebensburg, Pennsylvania, 15931 Phone: (814) 419-8107 |
News Archive
A University of Colorado School of Medicine researcher, hoping to find the cause of preeclampsia in pregnant women, won a $100,000 grant from the Bill & Melinda Gates Foundation Thursday which funds innovative global health and development projects.
Researchers from Charité - Universitätsmedizin Berlin have discovered a new way of developing painkillers.
Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.
The American Academy of Neurology and the American Brain Foundation are awarding the 2015 Potamkin Prize for Research in Pick's, Alzheimer's and Related Diseases to Peter Davies, PhD, of the Feinstein Institute for Medical Research in Manhasset, NY, and Reisa A. Sperling, MD, of the Brigham and Women's Hospital and Massachusetts General Hospital in Boston.
› Verified 2 days ago